Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
United Therapeutics Corp banner

United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 515.07 USD 0.92% Market Closed
Market Cap: $21.9B
Write Note Create Alert Ask AI

Wall St Price Targets

UTHR Price Targets Summary
United Therapeutics Corp

Wall Street analysts forecast UTHR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UTHR is 665.43 USD with a low forecast of 520.15 USD and a high forecast of 761.25 USD.

UTHR Lowest Forecast
Wall Street Target
$520.15
1% Upside
UTHR Average Forecast
Wall Street Target
$665.43
29% Upside
UTHR Highest Forecast
Wall Street Target
$761.25
48% Upside
Lowest Forecast
Price Target
520.15 USD
1% Upside
Average Forecast
Price Target
665.43 USD
29% Upside
Highest Forecast
Price Target
761.25 USD
48% Upside
United Therapeutics Corp Competitors:
Price Targets
JACK
Jack in the Box Inc
31% Upside
DXPE
DXP Enterprises Inc
-7% Downside
ENVX
Enovix Corp
245% Upside
JACK
Jack in the Box Inc
31% Upside
DXPE
DXP Enterprises Inc
-7% Downside
ENVX
Enovix Corp
245% Upside

Revenue
Forecast

10% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
10% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 13%.

What are analyst estimates?

Gross Profit
Forecast

10% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
10% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 6 years is 15%.

What are analyst estimates?

Operating Income
Forecast

10% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
10% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 14%.

What are analyst estimates?

Pre-Tax Income
Forecast

11% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
11% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 10%.

What are analyst estimates?

Net Income
Forecast

12% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
12% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 11%.

What are analyst estimates?

Continue UTHR Research

Summary
UTHR intrinsic value, competitors valuation, and company profile.
DCF Valuation
UTHR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
UTHR stock valuation using valuation multiples.
Wall St Estimates
UTHR price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
UTHR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other United Therapeutics Corp listings:
F • EUR
UTH
 XBER • EUR
UTH
 XMUN • EUR
UTH
 SWB • EUR
UTH
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is UTHR's stock price target?
Price Target
665.43 USD

According to Wall Street analysts, the average 1-year price target for UTHR is 665.43 USD with a low forecast of 520.15 USD and a high forecast of 761.25 USD.

What is the Revenue forecast for United Therapeutics Corp?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 13%.

What is the Gross Profit forecast for United Therapeutics Corp?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 6 years is 15%.

What is the Operating Income forecast for United Therapeutics Corp?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 14%.

What is the Pre-Tax Income forecast for United Therapeutics Corp?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 10%.

What is the Net Income forecast for United Therapeutics Corp?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 11%.

Back to Top
ALPHA SPREAD
Follow us
Join 355,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett